PALISADE BIO, INC. Research And Development Expense

Quick Answer

PALISADE BIO, INC. reported Research And Development Expense of $2.02 million for the year ending 2020.

  • PALISADE BIO, INC. showed a decrease of -50.3% in Research And Development Expense from 2019 to 2020.
  • This data is from PALISADE BIO, INC.'s annual report (Form 10-K), filed with the SEC on March 22, 2021.
  • XBRL data for this metric is available from 2009 to 2020 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 12 years of available data (2009 to 2020), PALISADE BIO, INC.'s Research And Development Expense has declined by 62.3%.
  • Historical annual values: Fiscal year 2020: $2.02 million | Fiscal year 2019: $4.06 million | Fiscal year 2018: $3.96 million | Fiscal year 2017: $8.10 million | Fiscal year 2016: $13.16 million | Fiscal year 2015: $12.64 million | Fiscal year 2014: $8.36 million | Fiscal year 2013: $7.29 million | Fiscal year 2012: $6.11 million | Fiscal year 2011: $7.35 million | Fiscal year 2010: $9.16 million | Fiscal year 2009: $5.35 million.
  • Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: